相关实验视频

Updated: Jan 6, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

神经导航的rTMS与SSRI结合治疗青少年抑郁症:有效性和神经机制

Xiaoyan Liu¹, Yaoyao Li¹, Yong Xia¹

¹Department of Psychiatry, Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, China.

Journal of affective disorders

|October 17, 2025

概括

通过神经导航引导的重复性跨磁刺激 (rTMS) 与药物治疗相结合,通过改变大脑活动和连接性,提供个性化治疗生物标志物,有效治疗青少年抑郁症.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
医疗成像医学成像

背景情况:

青少年重度抑郁症 (A-MDD) 涉及重复的情节与严重的症状.
目前的治疗方法旨在缓解症状并了解潜在的神经机制.
识别生物标志物对于个性化A-MDD治疗至关重要.

研究的目的:

在青少年中研究神经导航引导的rTMS与药物治疗相结合的抗抑郁疗效.
探索神经机制并确定与治疗反应相关的潜在生物标志物.
为了比较A-MDD患者与健康对照者的神经活动和连接性.

主要方法:

招募了49名A-MDD患者和31名健康对照 (HC).
甲-MDD组接受了SSRI药物治疗加上每天10次神经导航高频rTMS (HF-rTMS).
HC组接受了基线MRI扫描;A-MDD组接受了治疗前和后的MRI.

主要成果:

基线A-MDD患者表现出更高的HAMD得分,并在前额,顶部和前区域减少ALFF.
在治疗后,HAMD得分显著下降,在正面,面和部区域观察到ALFF增加.
功能连接 (FC) 分析显示,治疗后连接性普遍增加.

结论:

神经导航引导的rTMS与药物治疗相结合,在A-MDD中显示出抗抑郁药物的有效性.
治疗导致神经活动和连接性发生显著变化.
研究结果表明,针对个性化A-MDD治疗策略的潜在生物标志物.

关键词:

青少年青少年青少年高频重复性横性磁刺激高频重复性横性磁刺激大型抑郁症主要是抑郁症.神经导航是一种神经导航.静止状态功能磁共振成像技术

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...